Administration of vitamin D 50,000 units once monthly will: * Maintain serum 25-OH vitamin D above 20 ng/ml * Reduce falls * Increase calcaneal BMD * Reduce bone turnover * Be well tolerated: volunteers will not develop hypercalcemia * Improve performance on a swallowing quality of life questionnaire
1\. Research questions: We propose a prospective double-blind, randomized, placebo-controlled trial of once-monthly vitamin D oral capsules (50,000 units) in nursing-home residents. Subjects from several Wisconsin nursing homes were randomized to receive once-monthly vitamin D oral capsules (50,000 units) or placebo. Blood levels of 25-OH D, parathyroid hormone, serum calcium, and a marker of bone turnover will be measured periodically by standard lab assays. Swallowing quality of life was measured by questionnaire. Appropriate statistical tests (paired T tests, 95% confidence intervals will be calculated with the large sample approximation for binomial variables, other).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
96
University of Wisconsin
Madison, Wisconsin, United States
Plasma 25-hydroxyvitamin D levels
Time frame: 1 year
Plasma calcium
Time frame: one year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.